Skip to main content
. 2018 Jan 31;67(2):186–192. doi: 10.1093/cid/ciy076

Table 3.

Rotavirus-Specific Immunoglobulin A Seroconversion and Protection From Rotavirus Diarrhea Through 1 Year of Life

Group Seroconversion No RVD RVD RR (95% CI) P Valueb
No. (%) GMC [Range]a No. (%) GMC [Range]a
All (N = 564) Yes 107 (84.9) 19 (15.1) 0.52 (.34–.81) .002
108.5 [20.1–7297]c 57.2 [22.4–1017]c
No 311 (71.0) 127 (29.0)
<20 <20
Vaccinated (n = 279) Yes 69 (90.8) 7 (9.2) 0.47 (.22–1.00) .037
111.1 [20.1–7297] 77.6 [23.4–1017]
No 163 (80.3) 40 (19.7)
<20 <20
Unvaccinated (n = 285) Yes 38 (76.0) 12 (24.0) 0.65 (.39–1.09) .079
104.1 [20.9–3829]d 47.9 [22.4–338]d
No 148 (63.0) 87 (37.0)
<20 <20

Abbreviations: CI, confidence interval; GMC, geometric mean concentration; RR, relative risk; RVD, rotavirus diarrhea.

aComparison of GMC across groups performed by Mann-Whitney U test.

b P value by χ2 or Fisher exact test.

c P = .054.

d P = .046.